share_log

Wedbush Maintains Neutral on Bluebird Bio, Lowers Price Target to $1.68

Benzinga ·  Mar 19 09:09

Wedbush maintains bluebird bio (NASDAQ:BLUE) with a Neutral and lowers the price target from $3 to $1.68.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment